Clinical Trial Update: Drug-drug Interaction Between Belumosudil, Itraconazole, Rifampicin, Rabeprazole, and Omeprazole in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study assessing drug-drug interaction potential of belumosudil with several co-administered agents in healthy volunteers; results completed with posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Diseases
• Fibrotic Disease

Drugs mentioned

• Belumosudil (belumosudil)
• Itraconazole (Itraconazole)
• Omeprazole (Omeprazole)
• Rabeprazole (rabeprazole)
• Rifampicin

Snippet

Sponsor: Kadmon Corporation, LLC | Conditions: Drug-drug Interaction, Autoimmune Diseases | Phase 1 | Status: COMPLETED | Results posted: 2021-09-13